FOR TRANSLATIONAL RESEARCH IN NUCLEAR MEDICINE
Arronax Nantes brings together all stakeholders in Nantes working on research and development in nuclear medicine.
This more particularly include the GIP ARRONAX, the laboratories Ceisam, CEMA-Oniris, CRCINA, LS2N, Subatech, the CRIP-Oniris core facility and the Nuclear Medicine departments of the University Hospital of Nantes and the ICO.
Arronax Nantes is a stakeholder in the I-SITE NExT, in close collaboration with the LabEx IRON and the SIRIC ILIAD.
our publications
On the Interplay between Charge‐Shift Bonding and Halogen Bonding, Sarr S, Graton J, Montavon G, Pilmé J, Galland N, ChemPhysChem. 4 févr 2020;21(3):240‑50.
Advances in the Radiolabeling of Antibodies with Astatine-211: Toward Simplified Procedures and Improved Radiochemical Yields, Guérard F, Navarro L, Berdal M, Haddad F, Chérel M, Gestin J-F, Journal of Medical Imaging and Radiation Sciences. déc 2019;50(4):S99‑100.
our news
E-book : « Nuclear Medicine in the context of Personalized Medicine »
25/11/20
Vincent Fiegel explores the radiochemistry of superplasticizers
09/11/20
Some videos to discover medical radioactivity
20/10/20
PEPITES : a golden project for the Arronax beam
25/09/20
Radiation protection: teams under surveillance
22/09/20
